Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diagnostic
MedTech
GE mulls $1B imaging chemicals maker deal: Financial Times
GE HealthCare is said to be on the cusp of buying out radiopharmaceutical developer Sofie Biosciences, according to a report by the Financial Times.
Ben Adams
Sep 13, 2026 8:45am
Sanofi, Pangaea in pact to detect underdiagnosed genetic disease
Jun 22, 2026 9:00am
Roche sticks with €600M diagnostics investment in Germany
Jun 9, 2026 8:00am
Fierce Healthcare
GHO Capital, CBC Group to form $21B healthcare investment firm
May 20, 2026 12:30pm
Fierce Healthcare
Verily banks $300M to fuel AI road map, separates from Alphabet
Mar 19, 2026 6:00pm
Abbott device growth offsets diagnostics sales slide in Q3
Oct 15, 2025 11:00am